CN Stock MarketDetailed Quotes

688192 Dizal Pharmaceutical

Watchlist

41.50
-2.20-5.03%

Market Closed Oct 11 15:00 CST

17.25BMarket Cap-18387P/E (TTM)

Dizal Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dizal Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 936.750M	--
--	2024/FY	-- / 430.500M	--
--	2023/FY	91.289M / 108.000M	--
Mar 24, 2023	2022/FY	0.000 / 0.000	--
Feb 26, 2022	2021/FY	10.285M / 11.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 936.750M--

--2024/FY-- / 430.500M--

--2023/FY91.289M / 108.000M--

Mar 24, 20232022/FY0.000 / 0.000--

Feb 26, 20222021/FY10.285M / 11.000M--

Unlock Free Earnings Estimates

Open Account

Dizal Pharmaceutical Earnings Reports

Digel Pharmaceuticals: 2024 Semi-Annual Report

Aug 29 12:00 ET

Digel Pharmaceuticals: 2024 Semi-Annual Report Summary

Aug 29 12:00 ET

Dizal: 2023 Annual Report Summary

Apr 29 12:00 ET

Dizal: 2023 ANNUAL REPORT

Apr 29 12:00 ET

Analyst Rating

Updated: Oct 12, 2024

Strong Buy

Strong Buy
100.00%
Buy
0.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall